Akebia Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Welcome to the 19th Annual Morgan Stanley Healthcare Conference. I'm one of the biotech analysts, David Lebowitz. Before I get going, let me read through the requisite disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'm happy to have with me, for the next session, from Akebia, the CEO, John Butler, President and CEO; and the CFO, David Spellman. Clearly, a lot going on in your space these days with you and your competitors. I guess, if you could start off by just talking about the company, your overall mission and where you see the company heading.
Questions & Answers
Sure. First, David, thanks so much for the invitation. It
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |